SOURCE: Spiracur Inc.

Spiracur Inc.

January 18, 2011 09:00 ET

Spiracur Added to Marathon Medical's FSS Contract

SNaP Wound Care System Now Available Within U.S. Government's Healthcare System

SUNNYVALE, CA--(Marketwire - January 18, 2011) - Spiracur® Inc., the developer of an ultraportable and single-use, negative pressure wound therapy (NPWT) device, today announced it has been added to Marathon Medical's (Commerce City, CO) existing Federal Supply Schedule (FSS) contract, administered by the Department of Veterans Affairs (VA) on behalf of the U.S. General Services Administration (GSA).

The arrangement allows Spiracur to expand the availability of its SNaP® Wound Care System in partnership with Marathon Medical throughout the entire federal healthcare system, the largest healthcare provider in the United States with over 1,300 Veterans health facilities, Department of Defense medical treatment facilities, Military Hospitals, Indian Health Service Hospitals and other government agencies.

"We are very pleased to have secured this contract, which not only offers a multitude of opportunities to sell our innovative SNaP System, but ensures that veterans and active soldiers have access to our silent and lightweight device for proven wound treatment," said Dane Shackleford, vice president of sales, Spiracur Inc. "Our partnership with Marathon Medical offers a breadth of coverage within the VA system, as they have both the necessary experience and expertise in government agency sales."

Spiracur's SNaP Wound Care System (Smart Negative Pressure) is changing the approach of how NPWT is delivered to patients. Its inventive design eliminates electric or battery power in the healing process; therefore, the delivery device is completely silent, as well as lightweight and small (less than 3 oz). The SNaP Wound Care System is disposable and can easily fit under a patient's clothing, which has resulted in significantly improved patient acceptance and compliance of the therapy.

"The relationship with Spiracur is extremely important to Marathon Medical and our commitment to honor all fellow U.S. military veterans and active military personnel," said John St. Leger, president, Marathon Medical, a Service Disabled Veteran Owned Small Business and verified by the Center for Veterans Enterprise (CVE). "The ground-breaking SNaP Wound Care System offers the VA and Department of Defense facilities a significantly improved way of treating patients suffering from chronic wounds successfully, therefore avoiding more serious complications. And, the delivery mechanism of the SNaP System is more attractive to patients due to its size and ease-of-use."

The Snap Wound Care System was cleared by the FDA in August 2009 in a new therapy category the FDA has defined as "non-powered" NPWT devices. The device is indicated for patients who would benefit from a suction device for wound healing. The device is indicated for removal of small amounts of exudate (fluid) from chronic, acute, traumatic, subacute and dehisced wounds, as well as ulcers (such as diabetic or pressure), and surgically closed incisions.

The amendment of solicitation that added the SNaP Wound Care System from Spiracur went into effect January 1, 2011, and the GSA/FSS contract extends through November 2012 [Contract Number: V797P-4052B], with an option to renew in 2012 for a five-year contract.

About Marathon Medical:
Marathon Medical is dedicated to providing the highest quality products and services at competitive prices creating the best value for its customers. They serve the health care industry nationwide with products and services that help hospitals and pharmacies reduce costs, improve productivity and deliver better care to patients. Marathon Medical salutes the contracting officers, administration personnel, nurses and doctors who take care of this nation's heroes. They work diligently in concert with the contracting officers to combine excellent products with competitive pricing to bring the greatest value to the veteran patient.

About Spiracur Inc.
Spiracur Inc. is a privately held medical device company focused on the development of innovative wound healing technologies. Spiracur was founded out of the Stanford Biodesign Innovation Program in 2007. Its first product, the SNaP Wound Care System, grew out of the notion that current negative pressure wound therapies were too cumbersome for patients and clinicians. Spiracur strives to develop products that are truly patient-centric. For more information, please visit http://www.spiracur.com.

SNaP, Spiracur and the Spiracur Design are registered trademarks of Spiracur Inc.

Contact Information